Septic Shock in Patients With Solid Malignancies: What Does the Host Response Yield When the Host Is Already Under Threat?

Affiliations

¹ John T Miliken Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO; Healthcare Innovation Lab, BJC HealthCare, St. Louis, MO.
² John T Miliken Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO; Stem Cell Transplant and Oncology Intensive Care Unit, Barnes-Jewish Hospital, St. Louis, MO. Electronic address: c.mcevoy@wustl.edu.

Editorial

Patrick G Lyons et al. Chest. 2022 Nov.

. 2022 Nov;162(5):951-953.

doi: 10.1016/j.chest.2022.06.035.

¹ John T Miliken Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO; Healthcare Innovation Lab, BJC HealthCare, St. Louis, MO.
² John T Miliken Department of Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO; Stem Cell Transplant and Oncology Intensive Care Unit, Barnes-Jewish Hospital, St. Louis, MO. Electronic address: c.mcevoy@wustl.edu.

No abstract available

Comment on

Outcomes and Predictors of 28-Day Mortality in Patients With Solid Tumors and Septic Shock Defined by Third International Consensus Definitions for Sepsis and Septic Shock Criteria.
Cuenca JA, Manjappachar NK, Ramírez CM, Hernandez M, Martin P, Gutierrez C, Rathi N, Sprung CL, Price KJ, Nates JL. Cuenca JA, et al. Chest. 2022 Nov;162(5):1063-1073. doi: 10.1016/j.chest.2022.05.017. Epub 2022 May 26. Chest. 2022. PMID: 35644244 Free PMC article.